COPD
Pharmacists urged to check patient inhaler technique
Australian research shows up to 90% of patients incorrectly use their inhalers for asthma or chronic obstructive pulmonary disease (COPD) The National Asthma Council Australia is urging pharmacists and other …
Study to inform COPD treatment: Novartis
Novartis has welcomed the concurrent publication and presentation of findings from the FLAME study in the New England Journal of Medicine and at the 2016 American Thoracic Society International Conference …
World’s most prescribed COPD treatment goes combo
Boehringer Ingelheim has announced the availability of the first tiotropium-based combination therapy on the PBS for the treatment of chronic obstructive pulmonary disease (COPD).
Pharmacists’ role in lung health
Pharmacists can play a key role in educating people about their lungs… and keeping an eye on warning signs, write Dr Esther Lau and Professor Lisa Nissen Breathing is important. …
Spiriva first available therapy in new inhaler technology
Inhaler technology that revolutionises how medication is delivered to the lungs is now available in Australia and set to become the delivery platform for a range of inhaled therapies, says …
TB and COPD linked: researchers
Australian scientists have shown an important link between two, previously unconnected lung diseases: TB and COPD. While COPD has long been considered a smoker’s disease, 30% of cases have never …